A detailed history of Caitong International Asset Management Co., LTD transactions in Merus N.V. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 170 shares of MRUS stock, worth $6,834. This represents 0.01% of its overall portfolio holdings.

Number of Shares
170
Previous 170 -0.0%
Holding current value
$6,834
Previous $7.15 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$41.45 - $54.5 $7,046 - $9,265
170 New
170 $7.15 Million

Others Institutions Holding MRUS

About Merus N.V.


  • Ticker MRUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,878,200
  • Market Cap $1.84B
  • Description
  • Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...
More about MRUS
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.